COMP <GO>
UFPT vs MRK // ENTERPRISE SCALE & MARKET CAP
UFP Technologies Inc. (NASDAQ) VS. Merck & Company Inc. (NYSE) • 15-METRIC TALLY: UFPT 4
— MRK 9
▲ ENTERPRISE SCALE & MARKET CAP LEADER: MRK
LAST: $293.30 (+2.55%) • MKT CAP: $2.27B
market-cap
$2.27B
LAST: $146.33 (+3.83%) • MKT CAP: $361.02B
market-cap
$361.02B
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (UFPT VS. MRK)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | UFPT | MRK | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 28.30% | 74.80% | -46.50 | MRK | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 13.90% | 20.70% | -6.80 | MRK | /roic <GO> |
| EV/EBITDA & P/E Valuation | 25.7x | 15.3x | +10.40 | MRK | /valuation <GO> |
| Free Cash Flow Yield | 4.05% | 3.42% | +0.63 | UFPT | /fcf-yield <GO> |
| Operating Margin | 15.30% | 34.30% | -19.00 | MRK | /operating-margins <GO> |
| Net Profit Margin | 11.30% | 28.10% | -16.80 | MRK | /net-margins <GO> |
| Revenue Growth (YoY) | 19.50% | 1.30% | +18.20 | UFPT | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.26% | -2.26 | MRK | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 8.31 | 5.19 | +3.12 | UFPT | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 7/9 | +2.00 | UFPT | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 51.0 | 51.7 | -0.70 | MRK | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.92 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 28.0x | 18.4x | +9.60 | MRK | /forward-pe <GO> |
| Enterprise Scale & Market Cap ACTIVE | $2.27B | $361.02B | -$358.75B | MRK | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | UFPT REV | MRK REV | UFPT GROSS % | MRK GROSS % | UFPT FCF | MRK FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $602.8M | $65.01B | 28.3% | 74.8% | $91.9M | $12.36B |
| FY 2024 | $504.4M | $64.17B | 29.1% | 76.3% | $56.9M | $18.10B |
| FY 2023 | $400.1M | $60.12B | — | — | $41.3M | $10.30B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
UFPT // BETA —
MRK // BETA 0.92